Tubular epithelial injury and inflammation after ischemia and reperfusion in human kidney transplantation

Annals of Surgery

Volumn 253, Issue 3, 2011, Pages 598-604

  Snoeijs, Maarten G J ^a   Van Bijnen, Annemarie ^a   Swennen, Els ^a   Haenen, Guido R M M ^a   Roberts, L Jackson ^b   Christiaans, Maarten H L ^a   Peppelenbosch, Arnoud G ^a   Buurman, Wim A ^a   Ernest Van Heurn, L W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN C; CYTOKERATIN 18; ISOPROSTANE DERIVATIVE; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SODIUM;

ADULT; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; HEART DEATH; HUMAN; HUMAN TISSUE; KIDNEY CONCENTRATING CAPACITY; KIDNEY DONOR; KIDNEY INJURY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE EPITHELIUM; LIVING DONOR; MALE; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN URINE LEVEL; REPERFUSION INJURY; TISSUE INJURY;

ACETYLGLUCOSAMINIDASE; ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; CREATININE; CYSTATIN C; FEMALE; HUMANS; KERATIN-18; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; KIDNEY TUBULAR NECROSIS, ACUTE; KIDNEY TUBULES; LIPOCALINS; LIVING DONORS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS; REPERFUSION INJURY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UROTHELIUM; YOUNG ADULT;

EID: 79951671134     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31820d9ae9     Document Type: Article

References (48)

1. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet. 2004;364:1814-1827 (Pubitemid 39488068)
2. Yarlagadda SG, Coca SG, Formica RN Jr, et al. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant. 2009;24:1039-1047
3. Terasaki PI, Cho YW, Cecka JM. Strategy for eliminating the kidney shortage. Clin Transpl. 1997;265-267
4. Wijnen RM, Booster MH, Stubenitsky BM, et al. Outcome of transplantation of non-heart-beating donor kidneys. Lancet. 1995;345:1067-1070
5. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest. 1984;74:1156-1164 (Pubitemid 15206810)
6. Baker GL, Corry RJ, Autor AP. Oxygen free radical induced damage in kidneys subjected to warm ischemia and reperfusion. Protective effect of superoxide dismutase. Ann Surg. 1985;202:628-641 (Pubitemid 16245048)
7. Paller MS, Hedlund BE. Role of iron in postischemic renal injury in the rat. Kidney Int. 1988;34:474-480
8. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int. 2004;66:480-485 (Pubitemid 38981982)
9. Zhou W, Farrar CA, Abe K, et al. Predominant role for C5b-9 in renal is-chemia/reperfusion injury. J Clin Invest. 2000;105:1363-1371 (Pubitemid 30322402)
10. De Vries B, Matthijsen RA, Wolfs TG, et al. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation. 2003;75:375-382 (Pubitemid 36222966)
11. Kelly KJ, Williams WW Jr, Colvin RB, et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest. 1996;97:1056-1063 (Pubitemid 26070586)
12. Rosen S, Stillman IE. Acute tubular necrosis is a syndrome of physiologic and pathologic dissociation. J Am Soc Nephrol. 2008;19:871-875
13. Solez K, Racusen LC, Marcussen N, et al. Morphology of ischemic acute renal failure, normal function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients. Kidney Int. 1993;43:1058-1067 (Pubitemid 23137090)
14. Burns AT, Davies DR, McLaren AJ, et al. Apoptosis in ischemia/reperfusion injury of human renal allografts. Transplantation. 1998;66:872-876 (Pubitemid 28487460)
15. Koo DD, Welsh KI, Roake JA, et al. Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion. Am J Pathol. 1998;153:557-566 (Pubitemid 28373666)
16. Morrow JD, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198-1203
17. Handelman GJ, Walter MF, Adhikarla R, et al. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int. 2001;59: 1960-1966 (Pubitemid 32336813)
18. Snoeijs MG, Dekkers AJ, Buurman WA, et al. In situ preservation of kidneys from donors after cardiac death: results and complications. Ann Surg. 2007;246:844-852 (Pubitemid 350035662)
19. Espinel CH. The FENa test. Use in the differential diagnosis of acute renal failure. Jama. 1976;236:579-581
20. Dill DB, Costill DL. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol. 1974;37:247-248
21. Milne GL, Yin H, Brooks JD, et al. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods Enzymol. 2007;433:113-126
22. Fischer MA, Gransier TJ, Beckers LM, et al. Determination of the antioxidant capacity in blood. Clin Chem Lab Med. 2005;43:735-740
23. Matthews JN, Altman DG, Campbell MJ, et al. Analysis of serial measurements in medical research. BMJ. 1990;300:230-235 (Pubitemid 20045528)
24. Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14:2534-2543 (Pubitemid 37169339)
25. Wellwood JM, Ellis BG, Price RG, et al. Urinary N-acetyl- beta-D-glucosaminidase activities in patients with renal disease. Br Med J. 1975;3:408-411
26. Koyner JL, Bennett MR, Worcester EM, et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008;74:1059-1069
27. Kramer G, Erdal H, Mertens HJ, et al. Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res. 2004;64:1751-1756 (Pubitemid 38428698)
28. Kadiiska MB, Gladen BC, Baird DD, et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med. 2005;38:698-710 (Pubitemid 40249740)
29. Parikh CR, Jani A, Mishra J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006;6:1639-1645 (Pubitemid 43945804)
30. Hall IE, Yarlagadda SG, Coca SG, et al. IL-18 and Urinary NGAL Predict Dialysis and Graft Recovery after Kidney Transplantation. J Am Soc Nephrol. 2009
31. Wellwood JM, Davies D, Leighton M, Thompson AE. Urinary N-acetyl-beta-D-glucosaminidase assay in renal transplant recipients. Transplantation. 1978;26:396-400 (Pubitemid 9097790)
32. Oberbauer R, Rohrmoser M, Regele H, et al. Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol. 1999;10:2006-2013 (Pubitemid 29402523)
33. Castaneda MP, Swiatecka-Urban A, Mitsnefes MM, et al. Activation of mito-chondrial apoptotic pathways in human renal allografts after ischemiareperfu-sion injury. Transplantation. 2003;76:50-54 (Pubitemid 36877114)
34. Bonventre JV. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol. 2003;14( Suppl 1):S55-S61 (Pubitemid 36687041)
35. Hotchkiss RS, Strasser A, McDunn JE, et al. Cell death. N Engl J Med. 2009;361:1570-1583
36. Leemans JC, Stokman G, Claessen N, et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest. 2005;115:2894-2903 (Pubitemid 41434417)
37. Wu H, Chen G, Wyburn KR, et al. TLR4 activation mediates kidney is-chemia/reperfusion injury. J Clin Invest. 2007;117:2847-2859 (Pubitemid 47529615)
38. Kruger B, Krick S, Dhillon N, et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci USA. 2009;106:3390-3395
39. Kwon O, Molitoris BA, Pescovitz M, Kelly KJ. Urinary actin, interleukin-6, and interleukin-8 may predict sustained ARF after ischemic injury in renal allografts. Am J Kidney Dis. 2003;41:1074-1087 (Pubitemid 36532143)
40. Nechemia-Arbely Y, Barkan D, Pizov G, et al. IL-6/IL-6R axis plays a critical role in acute kidney injury. J Am Soc Nephrol. 2008;19:1106-1115
41. Chen L, Ahmed E, Wang T, et al. TLR signals promote IL-6/IL-17-dependent transplant rejection. J Immunol. 2009;182:6217-6225
42. Matthijsen RA, Huugen D, Hoebers NT, et al. Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion. Am J Pathol. 2007;171:1743-1752
43. Pollak R, Andrisevic JH, Maddux MS, et al. A randomized double-blind trial of the use of human recombinant superoxide dismutase in renal transplantation. Transplantation. 1993;55:57-60 (Pubitemid 23033945)
44. Rabl H, Khoschsorur G, Colombo T, et al. A multivitamin infusion prevents lipid peroxidation and improves transplantation performance. Kidney Int. 1993;43:912-917 (Pubitemid 23105227)
45. Land W, Schneeberger H, Schleibner S, et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation. 1994;57:211-217 (Pubitemid 24048587)
46. Shoskes D, Lapierre C, Cruz-Corerra M, et al. Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: a randomized placebo controlled trial. Transplantation. 2005;80:1556-1559 (Pubitemid 43005865)
47. Norio K, Wikstrom M, Salmela K, et al. Ascorbic acid against reperfusion injury in human renal transplantation. Transpl Int. 2003;16:480-485
48. Hower R, Minor T, Schneeberger H, et al. Assessment of oxygen radicals during kidney transplantation-effect of radical scavenger. Transpl Int. 1996;9 (Suppl 1):S479-S482